Skip to content

Does Vicks increase blood flow? Unpacking the science behind VapoRub's effects

4 min read

Recent research confirms that topical application of menthol, a key ingredient in Vicks VapoRub, can induce a localized increase in cutaneous (skin) blood flow. This effect, however, is very different from increasing systemic, or whole-body, blood circulation. Here is a pharmacological breakdown of the effects of Vicks.

Quick Summary

Vicks VapoRub contains active ingredients like menthol and camphor that act as counterirritants, creating a local warming or cooling sensation. This can trigger a minor, localized increase in blood flow to the skin, but it does not significantly impact systemic circulation throughout the body.

Key Points

  • Local Vasodilation: Vicks VapoRub can cause a minor, localized increase in blood flow to the skin (cutaneous vasodilation) at the application site.

  • Sensory Not Systemic: The effect is local and does not significantly increase systemic (whole-body) blood flow or affect overall blood pressure.

  • Counterirritant Effect: The sensation of coolness from menthol and warmth from camphor works by stimulating nerve endings to distract from underlying pain, a process known as counterirritation.

  • Limited Absorption: Systemic absorption through the skin is negligible with proper use, but applying it to mucous membranes like the nostrils can be toxic due to camphor absorption.

  • Menthol's Mechanism: Menthol activates cold-sensitive TRPM8 receptors, leading to local vasodilation via signaling pathways involving nitric oxide and sensory nerves.

  • Camphor's Mechanism: Camphor activates heat-sensitive TRPV1 and TRPV3 receptors, also contributing to local blood flow changes and pain relief.

  • Not a Cardiovascular Drug: Vicks is a topical analgesic and decongestant aid, not a treatment for cardiovascular conditions or blood circulation problems.

In This Article

The counterirritant effect: How Vicks works on a local level

Vicks VapoRub's perceived effect is often mistaken for a significant increase in blood flow. In reality, the sensation of warmth or coolness comes from its active ingredients—menthol, camphor, and eucalyptus oil—which act as counterirritants. A counterirritant works by distracting the nervous system from underlying pain signals. It does this by stimulating nerve endings in the skin, causing a mild irritation or sensation that effectively masks deeper aches and pains.

This process does involve some change in local blood vessels, but the effect is limited to the microcirculation just beneath the skin's surface and does not represent a measurable increase in overall systemic blood pressure or circulation. This is why Vicks is used for minor aches and pains or to create a feeling of decongestion rather than for serious circulatory issues.

The role of menthol and camphor

Menthol and camphor are the primary active components in VapoRub responsible for its pharmacological effects. They work through different mechanisms to create their signature sensations and local effects on blood flow.

  • Menthol: This ingredient is a selective agonist for the Transient Receptor Potential Melastatin-8 (TRPM8) receptor, also known as the "cold and menthol receptor". When applied to the skin, menthol activates these cold-sensitive receptors on sensory nerves, creating the cooling sensation associated with the product. This activation, through complex pathways involving nitric oxide (NO) and other substances, leads to a local vasodilation in the cutaneous microvasculature, increasing blood flow at the application site. However, some studies also show that in areas distant from the application site, a thermoregulatory vasoconstriction (narrowing of blood vessels) can occur in response to the perceived cold.
  • Camphor: Camphor is another counterirritant that interacts with Transient Receptor Potential (TRP) channels, specifically the heat-sensitive TRPV1 and TRPV3 receptors. This stimulation causes a warm sensation, and similar to menthol, it can increase local blood flow in the skin and muscle where it is applied. Camphor's action is part of the counterirritant strategy that helps alleviate minor pain.

Comparison: Vicks vs. Systemic Vasodilators

To understand why Vicks' effect on blood flow is not clinically significant for systemic circulation, consider the differences between its topical action and that of a true systemic vasodilator, such as nitroglycerin.

Feature Vicks VapoRub (Topical) Systemic Vasodilator (e.g., Nitroglycerin)
Mechanism of Action Activates nerve endings (TRP channels) to create local sensations and cause minor local blood vessel dilation. Acts systemically to relax the walls of larger blood vessels, such as arteries and veins, reducing overall blood pressure.
Effect on Blood Flow Minor, temporary increase in blood flow only in the skin's microcirculation at the application site. Significant and widespread relaxation of blood vessels throughout the body, reducing the workload on the heart.
Therapeutic Use Relief of minor muscle aches, joint pains, and cold-related congestion through sensory distraction. Treatment of conditions like hypertension, heart failure, and angina (chest pain).
Systemic Impact Negligible systemic absorption and no significant effect on overall blood pressure or circulation. Directly affects systemic vascular tone and blood pressure, requiring careful medical supervision.
Side Effects Skin irritation, burning sensation, potential toxicity if ingested or applied improperly. Dizziness, headaches, hypotension, and other systemic side effects.

Localized effects and safety considerations

The local effect of Vicks on blood flow is a byproduct of its primary function as a counterirritant, not its main therapeutic goal. For instance, in the case of muscular aches, the local vasodilation at the site of application is intended to help soothe the area and provide comfort, but this is a very minor, superficial effect. It is not equivalent to increasing blood supply to deep tissues or the cardiovascular system.

The local mechanism in practice

When you rub Vicks onto your skin, the active ingredients begin to interact with sensory nerves. The steps are as follows:

  1. The menthol activates TRPM8 receptors, triggering a nerve signal that is perceived by the brain as a cooling sensation. This is a neurosensory event, not a change in actual temperature.
  2. This sensory stimulation, along with the action of camphor, leads to a local release of vasodilatory compounds, such as nitric oxide, within the microvasculature.
  3. The vasodilation causes the blood vessels in the immediate area to widen, increasing local blood flow and causing a mild reddening of the skin.
  4. This increased superficial blood flow and the sensory distraction work together to create the feeling of relief from minor aches and discomfort.

Conclusion

Ultimately, the idea that Vicks significantly increases blood flow throughout the body is a myth. Its pharmacological effect on circulation is confined to the local microvasculature at the site of application. The sensation of relief comes from a complex interplay of sensory nerve stimulation and localized blood vessel changes, not a systemic circulatory increase. For this reason, Vicks is considered a topical analgesic and cough suppressant with no meaningful impact on overall cardiovascular health. It's important to use it as directed and never ingest it or apply it to mucous membranes, which can lead to toxic systemic absorption of camphor.

For more in-depth scientific information on the vascular effects of menthol, refer to the detailed review published in Frontiers in Physiology.

Frequently Asked Questions

No, Vicks VapoRub does not increase blood pressure when used as directed. Its effects are localized to the skin's surface and do not significantly impact the cardiovascular system.

The warming sensation from Vicks is a counterirritant effect caused by camphor activating heat-sensitive nerve receptors in the skin. While this can cause a minor increase in local blood flow, the sensation is primarily a neurosensory response.

When applied topically, menthol activates TRPM8 receptors in the skin. This triggers signaling pathways that can lead to local vasodilation, or a widening of small blood vessels in the skin, increasing cutaneous blood flow.

No, Vicks is not an appropriate treatment for poor circulation. Its effects on blood flow are strictly localized and superficial, and it has no systemic effect to address underlying circulatory issues.

A counterirritant is a substance that produces superficial irritation or a specific sensation to relieve pain or discomfort in another area. Menthol and camphor in Vicks are counterirritants that stimulate nerve endings in the skin to distract from muscle aches and pains.

When used externally as directed, there is no significant danger to blood circulation. However, ingesting Vicks or applying it to mucous membranes like the nose is dangerous and can lead to toxic systemic absorption of camphor, causing severe health problems.

No, Vicks does not increase blood flow to the lungs. The sensation of clearer airways comes from the menthol and camphor vapors interacting with nasal nerve endings, not from any physiological decongestant action.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.